EUVIMEDOpdag EUVIMED
Crossref

Antitumor activity of galaxamide involved in cell apoptosis and stemness by inhibiting Wnt/β‐catenin pathway in cervical cancer

Guang Yang, Yunbiao He, Yingxing Chen, Zhihan Huang, Jieqiong Huang, Xinyi Ren, Shihai Xu, Ping Li iD

Drug Development Research · 2023

DOI: 10.1002/ddr.22073 ↗

At a glance

Journal article in Drug Development Research, 2023. Written by Guang Yang and 7 co-authors. Institution: Department of Pathology, Jinan University School of Medicine, Guangzhou, China. Major MEDLINE topics: Wnt Signaling Pathway, Uterine Cervical Neoplasms. Cited 6 times so far (Crossref); 35 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Our previous work reported that galaxamide, a cyclopeptide extracted from the seaweed Galaxaura filamentosa, showed antiproliferative activity against HeLa cells by MTT assay. In this study, the growth‐inhibitory effects of galaxamide in HeLa cells and xenograft mouse models were investigated. It was found galaxamide significantly inhibited cell growth, colony formation, migration, and invasion and induced cell apoptosis by inhibiting the Wnt signaling pathway in HeLa cells. RNA sequencing revealed that galaxamide regulated stemness by Wnt6 signaling pathway in HeLa cells. By analyzing The Cancer Genome Atlas database, Wnt6 was found to be negatively/positively correlated with stemness‐ and apoptosis‐related genes in human cervical cancer. Cancer stem‐like cells (CSCs) isolated and enriched from HeLa cells demonstrated elevated Wnt6 and β‐catenin genes compared with nonstem HeLa cells. After galaxamide treatment, CSCs showed abrogation of sphere‐forming ability, along with inhibition of stemness‐related and Wnt pathway genes. Galaxamide treatment was also accompanied by the induction of apoptosis in HeLa cells, which was consistent with the results in BALB/c nude mice. Our results provide evidence that suppression of stemness by downregulating the Wnt signaling pathway is the molecular mechanism by which galaxamide effectively inhibits cell growth and induces apoptosis in cervical cancer cells.

Subjects

MeSH terms (MEDLINE)

Wnt Signaling PathwayUterine Cervical NeoplasmsFemaleHumansAnimalsMiceHeLa Cellsbeta CateninMice, NudePeptides, CyclicApoptosisCell ProliferationCell Line, Tumor

Author keywords

Wntcervical cancerseaweed

Substances

beta CateningalaxamidePeptides, Cyclic

Authors and institutions

  • Department of Pathology, Jinan University School of Medicine, Guangzhou, China.
  • Department of Chemistry, College of Chemistry and Material Science, Jinan University, Guangzhou, China.
  • Department of Medical Statistics, Jinan University School of Medicine, Guangzhou, China.
  • Department of Gynecology & Obstetrics, The First Affiliated Hospital of Jinan University, Jian University, Guangzhou, China.

ORCID profiles: Ping Li

Cite

APA

Yang, G., He, Y., Chen, Y., Huang, Z., Huang, J., Ren, X., Xu, S., & Li, P. (2023). Antitumor activity of galaxamide involved in cell apoptosis and stemness by inhibiting Wnt/β‐catenin pathway in cervical cancer. Drug Development Research. https://doi.org/10.1002/ddr.22073

Vancouver

Yang G, He Y, Chen Y, Huang Z, Huang J, Ren X, et al. Antitumor activity of galaxamide involved in cell apoptosis and stemness by inhibiting Wnt/β‐catenin pathway in cervical cancer. Drug Development Research. 2023. doi:10.1002/ddr.22073

BibTeX
@article{Yang2023,
  author = {Yang, Guang and He, Yunbiao and Chen, Yingxing and Huang, Zhihan and Huang, Jieqiong and Ren, Xinyi and Xu, Shihai and Li, Ping},
  title = {Antitumor activity of galaxamide involved in cell apoptosis and stemness by inhibiting Wnt/β‐catenin pathway in cervical cancer},
  journal = {Drug Development Research},
  year = {2023},
  doi = {10.1002/ddr.22073}
}
Start for free →